Mats Blom

Track

Insider profile

Performance

Overall performance

0.7

Performance over holding periods

0.7

	30 days	90 days	120 days
Average return	-2%	8.2%	15.1%
Success rate	0%	68%	82%
Transactions	1 100% Buy	34 71% Buy	47 69% Buy

Ranking by holding-period performance

Search

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-01-16	2026-01-14	Rare Thyroid Therapeutics International AB	B Purchase	20,268 104.66 SEK1,061,835	20,268	104.66	SEK1,061,835
2025-11-27	2025-11-26	Rare Thyroid Therapeutics International AB	B Purchase	1,637 254.84 SEK4,723,281	1,637	254.84	SEK4,723,281
2025-11-27	2025-11-26	Egetis Therapeutica AB	B Purchase	98,257 499.08 SEK4,337,495	98,257	499.08	SEK4,337,495
2025-11-27	2025-11-25	Rare Thyroid Therapeutics International AB	B Purchase	180,000 5.24 SEK943,200	180,000	5.24	SEK943,200
2025-11-27	2025-11-25	Egetis Therapeutica AB	B Purchase	180,000 5.24 SEK943,200	180,000	5.24	SEK943,200
2023-05-31	2023-05-31	Rare Thyroid Therapeutics International AB	B Purchase	200,000 4.96 SEK991,600	200,000	4.96	SEK991,600
2022-05-19	2022-05-17	Rare Thyroid Therapeutics International AB	B Purchase	677,250 3.65 SEK2,471,962	677,250	3.65	SEK2,471,962
2019-11-04	2019-11-04	Hansa Biopharma AB (HNSA)	B Purchase	1,000 123.17 SEK123,170	1,000	123.17	SEK123,170